Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing

Gemcitabine is a chemotherapy agent commonly used in the treatment of non-small cell lung cancer (NSCLC) that has been demonstrated to induce apoptosis in NSCLC cells by increasing functionally active Fas expression. The aim of this study was to evaluate the Fas/Fas ligand (FasL) system involvement...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Siena, Liboria, Pace, Elisabetta, Ferraro, Maria, Di Sano, Caterina, Melis, Mario, Profita, Mirella, Spatafora, Mario, Gjomarkaj, Mark
格式: Artigo
語言:Inglês
出版: Blackwell Publishing Ltd 2014
主題:
Original Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3904245/
https://ncbi.nlm.nih.gov/pubmed/24128051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imm.12190
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍